Motus GI Holdings MOTS · USD

Its shares trade under the ticker MOTS. It has been listed since 14 February 2018. In the fiscal year to 31 December 2023, it reported revenue of $319,000 and a net loss of $12.9m. At that date it held total assets of $7.2m and shareholders' equity of $2.7m.

Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2018-02-14. The firm is developing Pure-Vu system that integrates with existing colonoscopes to cleanse poorly prepped colons during the colonoscopy procedure. The Pure-Vu system uses a precise mixture of water and air to loosen debris from the colon mucosa while simultaneously evacuating the bowel contents, clearing the way for the endoscopist to perform a high quality examination, even when the patient is not fully clean prior to their procedure. The Pure-Vu System also helps in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon This device fits standard colonoscopes, allowing the physician to clean poorly-prepped colons in a safe and effective manner to gain clear visualization of the colon mucosa.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Jeff VarsalonePresident, Director, since 2024
• Ms. Ravit RamChief Financial Officer
• Mr. Elad AmorChief Accounting Officer
• Mr. Troy WilliamsInvestor Relations, since 2023

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.